ArticleCancer research and treatment2022

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients.

Yoon Ju Bang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.